Boothbay Fund Management’s Assembly Biosciences ASMB Stock Holding History

Boothbay Fund Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,784	Closed	-$44K	–	2237
2022 Q1	$44K	Hold	1,784	–	–	﹤0.01%	2190
2021 Q4	$50K	Hold	1,784	–	–	﹤0.01%	1774
2021 Q3	$74K	Buy	1,784 +22	+1%	+$922	﹤0.01%	1824
2021 Q2	$82K	Buy	1,762 +750	+74%	+$37.2K	﹤0.01%	1755
2021 Q1	$56K	Sell	1,012 -693	-41%	-$45.9K	﹤0.01%	1489
2020 Q4	$124K	Sell	1,705 -661	-28%	-$77.6K	﹤0.01%	1166
2020 Q3	$467K	Sell	2,366 -6,582	-74%	-$1.66M	0.03%	667
2020 Q2	$2.5M	Buy	8,948 +83	+0.9%	+$19.4K	0.17%	153
2020 Q1	$1.58M	Sell	8,865 -1,667	-16%	-$357K	0.13%	189
2019 Q4	$2.59M	Buy	10,532 +2,185	+26%	+$402K	0.23%	113
2019 Q3	$985K	Buy	8,347 +479	+6%	+$72.5K	0.09%	310
2019 Q2	$1.27M	Buy	+7,868	New	+$1.5M	0.12%	221

Other funds holding ASMB

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's ASMB Position: Q2 2022 in Review

Boothbay Fund Management sold out of Assembly Biosciences (ASMB) in Q2 2022, closing a stake of 1,784 shares — an estimated $44K sold.

Boothbay Fund Management first reported a position in ASMB in Q2 2019 and held it in 12 quarters. The position peaked at $2.59M in Q4 2019. 54 funds tracked by Wall St. Rank hold ASMB as of Q2 2022.

Boothbay Fund Management reported no remaining Assembly Biosciences position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 1,784 Assembly Biosciences shares in Q2 2022, an estimated $44K.
Boothbay Fund Management first reported a position in Assembly Biosciences in Q2 2019 and held it in 12 quarters.
Boothbay Fund Management's Assembly Biosciences position peaked at $2.59M in Q4 2019.
54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.